US Bancorp’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
US Bancorp's CDLX Position: Q3 2026 in Review
US Bancorp sold out of Cardlytics (CDLX) in Q3 2026, closing a stake of 54 shares — an estimated $242 sold.
US Bancorp first reported a position in CDLX in Q2 2020 and held it in 19 quarters. The position peaked at $31K in Q2 2021. 9 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.
- US Bancorp reported no remaining Cardlytics position as of Q3 2026 after selling out during the quarter.
- US Bancorp sold 54 Cardlytics shares in Q3 2026, an estimated $242.
- US Bancorp first reported a position in Cardlytics in Q2 2020 and held it in 19 quarters.
- US Bancorp's Cardlytics position peaked at $31K in Q2 2021.
- 9 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.
Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.